Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Abstract Text:

Bernd Hohenstein,Christian P M Hugo,Birgit Hausknecht,Kirsten P Boehmer,Regine H Riess,Roland E Schmieder,

BACKGROUND: Changes of renal nitric oxide (NO) production have been associated with glomerular hyperfiltration, vascular permeability, albuminuria, glomerulosclerosis and tubulointerstitial fibrosis. Several studies demonstrated an up- as well as downregulated expression of NO-synthases (NOS) in experimental diabetic nephropathy. It is still not yet specified whether the regulation and activity of NOS is changed in human diabetic nephropathy. METHODS: Renal biopsies and clinical data of 45 patients with diabetic nephropathy and of 10 control subjects were investigated. Glomerular and cortical endothelial NOS (eNOS) and inducible NOS (iNOS) expression were assessed by immunohistochemical staining and related to clinical data such as the duration of diabetes, insulin therapy and arterial hypertension, albuminuria/proteinuria, eGFR according to the formula modification of diet in renal disease (MDRD), presence of vascular complications or diabetic retinopathy. RESULTS: The mean age of patients at biopsy was 60.3 years and the mean duration of diabetes 12.9 years. Expression of cortical and glomerular eNOS was increased in type 2 diabetes (P < 0.05). Increased expression of glomerular and cortical eNOS correlated with more severe vascular complications (r = 0.44; P < 0.05). Glomerular eNOS was strongly increased among different degrees of proteinuria (P < 0.01). In contrast to expression levels of eNOS, the glomerular expression pattern of iNOS changed from an endothelial pattern in glomeruli with preserved morphology towards expression predominantly by inflammatory cells. CONCLUSIONS: Thus, increased eNOS expression by the renal endothelium could be demonstrated in type 2 diabetic nephropathy, whereas iNOS was unchanged but spatially differentially expressed. The eNOS expression was related to vascular lesions and the degree of proteinuria.

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Publishing Authors By Initials

B Hohenstein,CP Hugo,B Hausknecht,KP Boehmer,RH Riess,RE Schmieder,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Nephrology, dialysis, transplantation : official p

VOLUME: 23

Page Numbers: 1346-54

Journal Abbreviation: Nephrol. Dial. Transplant.

ISSN: 1460-2385

DAY: 9

MONTH: 12

YEAR: 2007

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8706402

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.

AFFILIATION: Roland E. Schmieder, Department of Nephrology and Hypertension, University Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany. Tel: +49-9131-8536245; Fax: +49-9131-8539209; E-mail: roland.schmieder@rzmail.uni-erlangen.de.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Nephrol Dial Transplant

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy Related Publications

• Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy.
• Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
• Analysis of retinal arteriolar structure in never-treated patients with essential hypertension.
• Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans.
• Computed tomographic angiography in the evaluation of clip placement for intracranial aneurysm.
• Current status of intraoperative real-time vibrography in neurosurgery.
• Deep venous thrombosis after lumbar disc surgery due to compression of the vena cava caused by a retroperitoneal haematoma.
• Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial.
• Effects of angiotensin II type 1-receptor blockade on retinal endothelial function.
• Heteronuclear NMR investigation on the structure and dynamics of the chromophore binding pocket of the cyanobacterial phytochrome Cph1.
• Hypertensive retinopathy: a window to vascular remodeling in arterial hypertension.
• Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes.
• Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
• Reliability and validity of ambulatory blood pressure recording in children.
• Risk reduction following regression of cardiac hypertrophy.
• Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.
• Salt intake as a determinant of cardiac hypertrophy.
• Structures of cyclic, antimicrobial peptides in a membrane-mimicking environment define requirements for activity.
• Treatment of degenerative cervical disc disease with uncoforaminotomy - intermediate clinical outcome.
• [Albuminuria: an indicator of cardiovascular risk]
• [Care of hypertensive patients seen by cardiologists: results of the Snapshot Hypertension Registry]
• [Combination therapy: used too little and too late?]
• [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?]
• [Health education and health propaganda in the latter half of life]
• [In Process Citation]
• [Not Available.]
• [Not Available.]
• [Occult sacral meningocele - a diagnostic challenge.]